Koers Pivotal Therapeutics Inc. Other OTC
Aandelen
PVTTF
CA72582E1043
Farmaceutische producten
Omzet 2013 | 0,3 0,28 | Omzet 2014 | 0,31 0,28 | Marktkapitalisatie | 5,56 mln. 5,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2014 | -5 mln. -4,61 mln. | EV/omzet 2013 | 54.242.447 x |
Nettoschuld 2013 | 1,48 mln. 1,37 mln. | Nettoschuld 2014 | 5,47 mln. 5,04 mln. | EV/omzet 2014 | 35.969.990 x |
K/w-verhouding 2013 |
-4,54
x | K/w-verhouding 2014 |
-1,03
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-10-10 | |
George Jackowski
FOU | Founder | - | 01-10-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Jackowski
FOU | Founder | - | 01-10-10 |
John Gebhardt
CHM | Chairman | 77 | 22-11-11 |
Founder | - | 01-10-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-9,58% | 6,8 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. |